EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Embryo Ploidy and Ovarian Response in Gonadotropin-Releasing Hormone Antagonist Versus Progestin-Primed Ovarian Stimulation Protocols with Recombinant Luteinizing Hormone: A Within-Patient Study

Merve Dizdar, Fazilet Kubra Boynukalin, Betul Dundar, Meral Gultomruk, Ibrahim Kale, Mustafa Bahceci, Gurkan Bozdag

Gynecology Obstetrics & Reproductive Medicine · 21.08.2026 · 1-7

DOI: 10.21613/gorm.2025.1725 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Gynecology Obstetrics & Reproductive Medicine, online erschienen am 21.08.2026. Verfasst von Merve Dizdar und 6 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: To compare embryo ploidy rates and ovarian response outcomes between gonadotropin-releasing hormone (GnRH) antagonist and progestin-primed ovarian stimulation (PPOS) cycles with recombinant luteinizing hormone (rLH) administered from stimulation onset. STUDY DESIGN: This retrospective within-patient cohort study included 41 women undergoing in vitro fertilization (IVF) with preimplantation genetic testing for aneuploidy (PGT-A) at a single center. Each patient completed both GnRH antagonist and PPOS cycles with rLH supplementation initiated on stimulation day 1. Cycles using GnRH agonists, urinary LH, random-start approaches, or with major gonadotropin dose discrepancies were excluded. The primary outcome was euploidy rate per biopsied blastocyst. Secondary outcomes included gonadotropin consumption, numbers of retrieved and mature oocytes, fertilization, blastulation, and euploidy per metaphase II (MII) oocyte. Paired t-tests or Wilcoxon signed-rank tests were used as appropriate. Statistical significance was set at p

Zitieren

APA

Dizdar, M., Boynukalin, F. K., Dundar, B., Gultomruk, M., Kale, I., Bahceci, M., & Bozdag, G. (2026). Embryo Ploidy and Ovarian Response in Gonadotropin-Releasing Hormone Antagonist Versus Progestin-Primed Ovarian Stimulation Protocols with Recombinant Luteinizing Hormone: A Within-Patient Study. Gynecology Obstetrics & Reproductive Medicine, 1-7. https://doi.org/10.21613/gorm.2025.1725

Vancouver

Dizdar M, Boynukalin FK, Dundar B, Gultomruk M, Kale I, Bahceci M, et al. Embryo Ploidy and Ovarian Response in Gonadotropin-Releasing Hormone Antagonist Versus Progestin-Primed Ovarian Stimulation Protocols with Recombinant Luteinizing Hormone: A Within-Patient Study. Gynecology Obstetrics & Reproductive Medicine. 2026:1-7. doi:10.21613/gorm.2025.1725

BibTeX
@article{Dizdar2026,
  author = {Dizdar, Merve and Boynukalin, Fazilet Kubra and Dundar, Betul and Gultomruk, Meral and Kale, Ibrahim and Bahceci, Mustafa and Bozdag, Gurkan},
  title = {Embryo Ploidy and Ovarian Response in Gonadotropin-Releasing Hormone Antagonist Versus Progestin-Primed Ovarian Stimulation Protocols with Recombinant Luteinizing Hormone: A Within-Patient Study},
  journal = {Gynecology Obstetrics & Reproductive Medicine},
  year = {2026},
  pages = {1--7},
  doi = {10.21613/gorm.2025.1725}
}
Kostenlos starten →